NOVA EYE MEDICAL LIMITED
ASX:EYEHealth Care Equipment & ServicesRunway 2–4 quarters; share count grew 24% in 24 months; 1 cash raise in 24 months
NOVA EYE MEDICAL LIMITED's ordinary share count grew 24.4% between August 2024 and July 2026, to 285M shares. The company raised capital once in the past 24 months, with a A$6.6M placement in January 2025. Options and rights on issue represent 0% of the current share count. At the June 2026 quarter, the company reported A$747K in available cash, covering approximately 2.8 quarters of its recent spending rate. No proposed securities issues are pending.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | On issue, per this filing | Source |
|---|---|---|---|---|
| 5 Aug 2026 | 3H · cancellation | EYE : ORDINARY FULLY PAID | 284.9M | Appendix 3H |
| 10 July 2026 | 2A · quoted issue | EYE : ORDINARY FULLY PAID | 284.9M | Appendix 2A |
| 25 June 2026 | 3H · cancellation | EYE : ORDINARY FULLY PAID | 284.9M | Appendix 3H |
| 25 June 2026 | 3H · cancellation | EYE : ORDINARY FULLY PAID | 284.9M | Appendix 3H |
| 6 May 2026 | 2A · quoted issue | EYE : ORDINARY FULLY PAID | 284.9M | Appendix 2A |
Capital raises
1 cash raise in the last 24 months · 0 in the last 12 months
Forward supply
Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.
Placement capacity
How much stock a company can place without asking holders. Listing Rule 7.1 allows 15% of ordinary securities in any 12 months, and every Appendix 3B states how much of it an issue uses.
Pending proposed issues
Options & convertible securities
No option supply on record carries an exercise price to pay, so no share price switches any of it on. All 49k of it converts on something else — a hurdle that may never be met, or terms the filing does not price.
| Code | Security | Type | Exercise price | Expiry | On issue | Source |
|---|---|---|---|---|---|---|
| EYEAC | Performance rights | Condition-triggered | — | — | 49k | Filing Meeting |
“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column.
A condition-triggered class has no exercise price and usually no expiry: what it vests on is set by a shareholder resolution, not by the register. Where the company lodged a notice of meeting before the class first appears here, it is linked as “Meeting” — that is where terms of this kind are put to shareholders. It is not confirmation that the document sets this class’s conditions, and no link appears where there is no such filing.
Director dealings
| Date | Director | Type | Shares | Options | Other | Value | Source |
|---|---|---|---|---|---|---|---|
| 27 Aug 2026 | Thomas Anthony Spurling | Buy on-market | 160k | — | — | $117k | 3Y notice |
| 1 Sept 2025 | Thomas Anthony Spurling | Buy off-market | 78k | — | — | — | 3Y notice |
| 4 Aug 2025 | Thomas Anthony Spurling | Other incentive | 300k | — | — | — | 3Y notice |
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 12 Sept 2026.